Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL-112) LEUKEMIA LYMPHOMA
A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing BIOCHEM SOC T
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment Biomed Pharmacother
Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement Front Immunol
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma NAT COMMUN
Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma Cell Death Discov